256 related articles for article (PubMed ID: 18267277)
41. Long-term course of substantia nigra hyperechogenicity in Parkinson's disease.
Behnke S; Runkel A; Kassar HA; Ortmann M; Guidez D; Dillmann U; Fassbender K; Spiegel J
Mov Disord; 2013 Apr; 28(4):455-9. PubMed ID: 23115064
[TBL] [Abstract][Full Text] [Related]
42. Transcranial sonography in Parkinson's disease.
Bor-Seng-Shu E; Pedroso JL; Andrade DC; Barsottini OG; Andrade LA; Barbosa ER; Teixeira MJ
Einstein (Sao Paulo); 2012; 10(2):242-6. PubMed ID: 23052464
[TBL] [Abstract][Full Text] [Related]
43. Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.
Berg D
J Neural Transm (Vienna); 2011 Mar; 118(3):453-61. PubMed ID: 20830493
[TBL] [Abstract][Full Text] [Related]
44. Can we image premotor Parkinson disease?
Marek K; Jennings D
Neurology; 2009 Feb; 72(7 Suppl):S21-6. PubMed ID: 19221310
[TBL] [Abstract][Full Text] [Related]
45. [Transcranial sonography in Parkinson's disease].
Fedotova EIu; Chechetkin AO; Shadrina MI; Slominskiĭ PA; Ivanova-Smolenskaia IA; Illarioshkin SN
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(1):49-55. PubMed ID: 21350412
[TBL] [Abstract][Full Text] [Related]
46. Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers.
Ruprecht-Dörfler P; Klotz P; Becker G; Berg D
Parkinsonism Relat Disord; 2007 Aug; 13(6):362-4. PubMed ID: 17055330
[TBL] [Abstract][Full Text] [Related]
47. A population-based study on combined markers for early Parkinson's disease.
Tunc S; Graf J; Tadic V; Brüggemann N; Schmidt A; Al-Khaled M; Wolff S; Vollstedt EJ; Lorwin A; Hampf J; Piskol L; Klein C; Hagenah J; Kasten M
Mov Disord; 2015 Apr; 30(4):531-7. PubMed ID: 25546094
[TBL] [Abstract][Full Text] [Related]
48. Distinguishing Parkinson's disease and essential tremor with transcranial sonography.
Budisic M; Trkanjec Z; Bosnjak J; Lovrencic-Huzjan A; Vukovic V; Demarin V
Acta Neurol Scand; 2009 Jan; 119(1):17-21. PubMed ID: 18549415
[TBL] [Abstract][Full Text] [Related]
49. Imaging approaches to Parkinson disease.
Brooks DJ
J Nucl Med; 2010 Apr; 51(4):596-609. PubMed ID: 20351351
[TBL] [Abstract][Full Text] [Related]
50. Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET.
Behnke S; Schroeder U; Dillmann U; Buchholz HG; Schreckenberger M; Fuss G; Reith W; Berg D; Krick CM
Neuroimage; 2009 Oct; 47(4):1237-43. PubMed ID: 19497378
[TBL] [Abstract][Full Text] [Related]
51. Transcranial sonography findings in welding-related Parkinsonism in comparison to Parkinson's disease.
Walter U; Dressler D; Lindemann C; Slachevsky A; Miranda M
Mov Disord; 2008 Jan; 23(1):141-5. PubMed ID: 17987651
[TBL] [Abstract][Full Text] [Related]
52. Does ultrasound disclose a vulnerability factor for Parkinson's disease?
Behnke S; Berg D; Becker G
J Neurol; 2003 Feb; 250 Suppl 1():I24-7. PubMed ID: 12761631
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study.
Liepelt-Scarfone I; Gauss K; Maetzler W; Müller K; Bormann C; Fruhmann Berger M; Timmers M; Streffer J; Berg D
Neuroepidemiology; 2013; 41(3-4):174-82. PubMed ID: 24051361
[TBL] [Abstract][Full Text] [Related]
54. [Transcraniel ultrasound in the differential diagnosis of Parkinson's disease].
Woitalla D; Braak H; Del Tredici K; Fogel W; Hagenah J; Oertel W; Berg D
Fortschr Neurol Psychiatr; 2010 Mar; 78 Suppl 1():S25-30. PubMed ID: 20195938
[TBL] [Abstract][Full Text] [Related]
55. Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder.
Miyamoto M; Miyamoto T; Iwanami M; Muramatsu S; Asari S; Nakano I; Hirata K
Sleep Med; 2012 Jan; 13(1):102-6. PubMed ID: 22033122
[TBL] [Abstract][Full Text] [Related]
56. Imaging neurodegeneration in Parkinson's disease.
Pavese N; Brooks DJ
Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
[TBL] [Abstract][Full Text] [Related]
57. Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population.
Liepelt I; Wendt A; Schweitzer KJ; Wolf B; Godau J; Gaenslen A; Bruessel T; Berg D
J Neural Transm (Vienna); 2008 Jul; 115(7):993-9. PubMed ID: 18368284
[TBL] [Abstract][Full Text] [Related]
58. Accuracy of Transcranial Sonography of the Substantia Nigra for Detection of Parkinson's Disease: A Systematic Review and Meta-analysis.
Tao A; Chen G; Deng Y; Xu R
Ultrasound Med Biol; 2019 Mar; 45(3):628-641. PubMed ID: 30612821
[TBL] [Abstract][Full Text] [Related]
59. Predictors for mild parkinsonian signs: a prospective population-based study.
Mahlknecht P; Kiechl S; Stockner H; Willeit J; Gasperi A; Poewe W; Seppi K
Parkinsonism Relat Disord; 2015 Mar; 21(3):321-4. PubMed ID: 25585991
[TBL] [Abstract][Full Text] [Related]
60. Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency.
Hoeppner J; Prudente-Morrissey L; Herpertz SC; Benecke R; Walter U
Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):92-7. PubMed ID: 18806917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
